Pill bottle meets fitbit: new study aims to boost med adherence in breast cancer survivors
NCT ID NCT06865755
First seen Apr 30, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study tests whether a system combining a smartphone app, a special pill bottle (Wisepill), and a Fitbit can help breast cancer survivors take their daily hormone therapy consistently. Fifteen survivors aged 21-70 will use the system for six months and share their experiences through surveys. The goal is to see if this technology makes it easier to stick with long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
San Diego State University
San Diego, California, 92120, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.